Showing results (251-260 of 276) with videos related to

Sort By:
Pageof 28
Journal of Medicinal Chemistry|November 15, 2002
Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 3. Structure activity relationships at C3(1,2)Eddy W Yue, C Anne Higley, Susan V DiMeo, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2023
Synthesis and biological evaluation of biaryl alkyl ethers as inhibitors of IDO1Jay A Markwalder, Aaron J Balog, David K Williams, et al.
Journal of Medicinal Chemistry|November 13, 2004
Synthesis and biological evaluation of 1-aryl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of cyclin-dependent kinasesJay A Markwalder, Marc R Arnone, Pamela A Benfield, et al.
ACS Medicinal Chemistry Letters|February 19, 2021
Discovery and Preclinical Evaluation of BMS-986242, a Potent, Selective Inhibitor of Indoleamine-2,3-dioxygenase 1Emily C Cherney, Liping Zhang, Susheel Nara, et al.
Molecular Cancer Therapeutics|May 18, 2005
Matrix metalloproteinase-activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicityCharles F Albright, Nilsa Graciani, Wei Han, et al.
American Journal of Respiratory and Critical Care Medicine|March 6, 2023
Individualized Treatment Effects of Bougie versus Stylet for Tracheal Intubation in Critical IllnessKevin P Seitz, Alexandra B Spicer, Jonathan D Casey, et al.
Medrxiv : the Preprint Server for Health Sciences|August 7, 2023
Protocol and statistical analysis plan for the Mode of Ventilation During Critical IllnEss (MODE) trialKevin P Seitz, Bradley D Lloyd, Li Wang, et al.
CHEST Critical Care|May 14, 2024
Protocol and Statistical Analysis Plan for the Mode of Ventilation During Critical Illness (MODE) TrialKevin P Seitz, Bradley D Lloyd, Li Wang, et al.
Pageof 28